TAB, Nothing in terms of the pathway for Prurisol is a fact until the FDA says so. FDA could say fine, start your Ph3 trial at these dosages. Or they could say to work out several doses in a Ph2b which is allowed to transition directly into Ph3 at what Ph2b determines is an optimal dose. Also possible FDA could just ask us to do an added Ph2b by itself at several dosages before they approve starting Ph3.

Regardless, we are moving forward and Leo is batting 1000.